Ovalbumin-induced experimental allergic asthma is Toll-like receptor 2 dependent

Allergy and Asthma Proceedings

Volumn 35, Issue 2, 2014, Pages

  Li, Xiaodi ^a   Chen, Qiu ^b   Chu, Chu ^a   You, Haizhang ^a   Jin, Meifang ^a   Zhao, Xianhong ^a   Zhu, Xueming ^a   Zhou, Weifang ^a   Ji, Wei ^a  

^a CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; OVALBUMIN; PROTEIN KINASE B; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE;

ADAPTIVE IMMUNITY; AEROSOL; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRONCHUS DISEASE; CONTROLLED STUDY; GENE DELETION; LUNG FIBROSIS; MALE; METAPLASIA; MOUSE; MUCUS; NONHUMAN; RESPIRATORY TRACT INFLAMMATION; TH2 CELL; ANIMAL; ASTHMA; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; OVALBUMIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TH2 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 84897100756     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.3735     Document Type: Article

References (29)

1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183-192, 2008. (Pubitemid 351323287)
2. Muniz-Junqueira MI, Barbosa-Marques SM, and Junqueira LF Jr. Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children. Allergy 68:911-920, 2013.
3. Lauzon-Joset JF, Marsolais D, Langlois A, and Bissonnette EY. Dysregulation of alveolar macrophages unleashes dendritic cell-mediated mechanisms of allergic airway inflammation. Mucosal Immunol 7:155-164, 2014.
4. Klein Wolterink RG, Kleinjan A, van Nimwegen M, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42:1106-1116, 2012.
5. Franova S, Joskova M, Sadlonova V, et al. Experimental model of allergic asthma. Adv Exp Med Biol 756:49-55, 2013.
6. Duan W, Aguinaldo Datiles AM, Leung BP, et al. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5:495-502, 2005. (Pubitemid 40430757)
7. Duan W, Chan JH, Wong CH, et al. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 172:7053-7059, 2004. (Pubitemid 38669147)
8. Duan W, Chan JH, McKay K, et al. Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med 171:571-578, 2005. (Pubitemid 40365411)
9. Paul B, Mishra V, Chaudhury B, et al. Status of Stat3 in an ovalbumin-induced mouse model of asthma: Analysis of the role of Socs3 and IL-6. Int Arch Allergy Immunol 148:99-108, 2009.
10. Kim HR, Lee DM, Lee SH, et al. Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: Activation of STAT-6 and JNK is inhibited by chlorogenic acid. Int Immunopharmacol 10:1242-1248, 2010.
11. Chisholm D, Libet L, Hayashi T, et al. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities. J Allergy Clin Immunol 113:448-454, 2004. (Pubitemid 38338949)
12. Redecke V, Häcker H, Datta SK, et al. Cutting edge: Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2739-2743, 2004. (Pubitemid 38263655)
13. Akdis CA, Kussebi F, Pulendran B, et al. Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol 33:2717-2726, 2003. (Pubitemid 37337137)
14. Patel M, Xu D, Kewin P, et al. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174:7558-7563, 2005. (Pubitemid 40806259)
15. Velasco G, Campo M, Manrique JO, et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 32:218-224, 2005. (Pubitemid 40387648)
16. Nawijn MC, Motta AC, Gras R, et al. TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice. PLoS One 8:e55307, 2013.
17. Buckland KF, O'Connor E, Murray LA, et al. Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res 57:379-387, 2008.
18. Page K, Ledford JR, Zhou P, et al. A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. J Immunol 183:3400-3408, 2009.
19. Fuchs B, Knothe S, Rochlitzer S, et al. A Toll-like receptor 2/6 agonist reduces allergic airway inflammation in chronic respiratory sensitisation to Timothy grass pollen antigens. Int Arch Allergy Immunol 152:131-139, 2010.
20. Jin H, Kumar L, Mathias C, et al. Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. J Allergy Clin Immunol 123:875-882, 2009.
21. Agrawal S, Agrawal A, Doughty B, et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol 171:4984-4989, 2003. (Pubitemid 37432777)
22. Kim SR, Lee KS, Park SJ, et al. Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease. J Clin Immunol 32:574-586, 2012.
23. Galli SJ, Tsai M, and Piliponsky AM. The development of allergic inflammation. Nature 454:445-454, 2008.
24. Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma: A summary of the evidence. Eur Respir J 27:615-626, 2006. (Pubitemid 43372538)
25. Lam D, Ng N, Lee S, et al. Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways. J Immunol 181:2925-2932, 2008.
26. Liu CF, Drocourt D, Puzo G, et al. Innate immune response of alveolar macrophage to house dust mite allergen is mediated through TLR2/-4 co-activation. PLoS One 8:e75983, 2013.
27. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97:13766-13771, 2000.
28. Horng T, Barton GM, Flavell RA, et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333, 2002. (Pubitemid 35398189)
29. Strassheim D, Asehnoune K, Park JS, et al. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils. J Immunol 172:5727-5733, 2004. (Pubitemid 38542078)